| 12377100 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Gregory Chin, Richard L. Mackman, Michael R. Mish, Hyung-Jung Pyun +1 more |
2025-08-05 |
|
| 12338220 |
Antiviral pyrazolopiridinone compounds |
Zef Konst, Yipin Lu, Robert Joseph Moreau, Naomi Rajapaksa, Galen Paul Shearn-Nance +5 more |
2025-06-24 |
|
| 12338233 |
PD-1/Pd-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2025-06-24 |
|
| 12269812 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more |
2025-04-08 |
|
| 12037342 |
Substituted eneoxindoles and uses thereof |
Evangelos Aktoudianakis, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Kristyna M. Elbel +5 more |
2024-07-16 |
$290,202,000 |
| 11667613 |
Antiviral pyrazolopyridinone compounds |
Zef Konst, Yipin Lu, Robert Joseph Moreau, Naomi Rajapaksa, Galen Paul Shearn-Nance +5 more |
2023-06-06 |
$71,694,000 |
| 11555029 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2023-01-17 |
$669,972,000 |
| 11453681 |
Substituted eneoxindoles and uses thereof |
Evangelos Aktoudianakis, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Kristyna M. Elbel +5 more |
2022-09-27 |
$455,166,000 |
| 11236085 |
PD-1/PD-L1 inhibitors |
Zhimin Du, Michael Graupe, Paulo A. Machicao Tello, Jonathan William Medley, Eric Q. Parkhill +5 more |
2022-02-01 |
$369,757,000 |
| 10988498 |
Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs |
Thomas Butler, Aesop Cho, Benjamin R. Graetz, Choung U. Kim, Oliver L. Saunders +3 more |
2021-04-27 |
$236,030,000 |
| 10899735 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2021-01-26 |
$775,784,000 |
| 10774071 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more |
2020-09-15 |
$253,208,000 |
| 10710986 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2020-07-14 |
$847,542,000 |
| 10442804 |
Compounds for the treatment of hepatitis B virus infection |
Evangelos Aktoudianakis, Eda Canales, Kevin S. Currie, Darryl Kato, Jiayao Li +7 more |
2019-10-15 |
$386,222,000 |
| 10285990 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Gregory Chin, Richard L. Mackman, Michael R. Mish, Hyung-Jung Pyun +1 more |
2019-05-14 |
$195,322,000 |
| 10023600 |
Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs |
Thomas Butler, Aesop Cho, Benjamin R. Graetz, Choung U. Kim, Oliver L. Saunders +3 more |
2018-07-17 |
$510,065,000 |
| 10017501 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +10 more |
2018-07-10 |
$525,460,000 |
| 9670205 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Gregory Chin, Richard L. Mackman, Michael R. Mish, Hyung-Jung Pyun +1 more |
2017-06-06 |
$404,622,000 |
| 9458145 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +10 more |
2016-10-04 |
$144,218,000 |
| 9255089 |
Benzimidazolone derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +8 more |
2016-02-09 |
$342,012,000 |
| 8008287 |
Integrase inhibitors |
Zhenhong R. Cai, Salman Y. Jabri, Haolun Jin, Rachael Lansdown, Michael R. Mish +1 more |
2011-08-30 |
$76,134,000 |
| 7998950 |
Antiviral compounds |
Evangelos Aktoudianakis, Azim A. Celebi, Zhimin Du, Salman Y. Jabri, Haolun Jin +7 more |
2011-08-16 |
$79,647,000 |
| 7973013 |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
Aesop Cho, Choung U. Kim, Adrian S. Ray, Jie Xu |
2011-07-05 |
$77,380,000 |
